Introduction
The CATCHIMERA platform was provided to evaluate and monitor the recurrence clonality after tumor resection, through vh-DNA released from residual tumor. The vh-DNAmarker provides advantages for detecting tumor cells for HCC.
Features / strengths
minimal invasive procedure, positive rate is higher than AFP, and can be detected earlier than CT imaging
Specification in detail
Certification
ISO/IEC 17025:2017 ;CNS 17025:2018
